asciminib

⇄

c-abl oncogene 1, non-receptor tyrosine kinase ; Mus musculus







1 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34659899 Asciminib and ponatinib exert synergistic anti-neoplastic effects on CML cells expressing BCR-ABL1 T315I-compound mutations. 2021 3